LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Efficacy of R2CHA2DS2-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation

Photo by jeffreyflin from unsplash

Background There is no data specific to the addition of renal dysfunction and age 50–64 years as risk parameters to the CHA 2 DS 2 -VA score, which is known as… Click to show full abstract

Background There is no data specific to the addition of renal dysfunction and age 50–64 years as risk parameters to the CHA 2 DS 2 -VA score, which is known as the R 2 CHA 2 DS 2 -VA score, among NVAF patients. Accordingly, the aim of this study was to validate the R 2 CHA 2 DS 2 -VA score for predicting thromboembolism in Thai NVAF patients. Methods Thai NVAF patients were prospectively enrolled in a nationwide multicenter registry from 27 hospitals during 2014–2020. Each component of the CHA 2 DS 2 -VA and R 2 CHA 2 DS 2 -VA scores was scored and recorded. The main outcomes were thromboembolism, including ischemic stroke, transient ischemic attack (TIA), and/or systemic embolism. The annual incidence rate of thromboembolism among patients in each R 2 CHA 2 DS 2 -VA and CHA 2 DS 2 -VA risk score category is shown as hazard ratio (HR) and 95% confidence interval (95% CI). The performance of the R 2 CHA 2 DS 2 -VA and CHA 2 DS 2 -VA scores was demonstrated using c-statistics. Net reclassification index was calculated. Calibration plat was used to assess agreement between observed probabilities and predicted probabilities of both scoring system. Results A total of 3402 patients were enrolled during 2014–2020. The average age of patients was 67.38 ± 11.27 years. Of those, 46.9% had renal disease, 30.7% had a history of heart failure, and 17.1% had previous stroke or TIA. The average R 2 CHA 2 DS 2 -VA and CHA 2 DS 2 -VA scores were 3.92 ± 1.92 and 2.98 ± 1.43, respectively. Annual thromboembolic risk increased with incremental increase in R 2 CHA 2 DS 2 -VA and CHA 2 DS 2 -VA scores. Oral anticoagulants had benefit in stroke prevention in NVAF patients with an R 2 CHA 2 DS 2 -VA score of 2 or more (adjusted HR: 0.630, 95% CI 0.413–0.962, p  = 0.032). The c-statistics were 0.630 (95% CI 0.61–0.65) and 0.627 (95% CI 0.61–0.64), for R 2 CHA 2 DS 2 -VA and CHA2DS2-VA scores respectively. NRI was 2.2%. The slope and R2 of the calibration plot were 0.73 and 0.905 for R 2 CHA 2 DS 2 -VA and 0.70 and 0.846 for CHA 2 DS 2 -VA score respectively. Conclusions R 2 CHA 2 DS 2 -VA score was found to be at least as good as CHA 2 DS 2 -VA score for predicting thromboembolism in Thai patients with NVAF. Similar to CHA 2 DS 2 -VA score, thromboembolism increased with incremental increase in R 2 CHA 2 DS 2 -VA score.

Keywords: score predicting; cha score; predicting thromboembolism; cha

Journal Title: BMC Cardiovascular Disorders
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.